Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Xeomin for chronic sialorrhea

July 4, 2018

Evotec closes strategic transaction with Sanofi

July 4, 2018

FDA awards orphan drug designation to N-Rephasin for treatment of anthrax

July 4, 2018

Copeptin could be used to diagnose obesity-induced insulin resistance

July 4, 2018

Jiangsu Nhwaluokang Pharmaceutical discovers allopregnanolone prodrugs

July 4, 2018

Titan postpones enrollment in next cohort of phase I/II trial of ropinirole implant

July 4, 2018

Spiramycin approved in Japan for treatment of toxoplasmosis during pregnancy

July 4, 2018

New P2X4 antagonists synthesized by Bayer

July 4, 2018

Sorrento acquires Sofusa lymphatic delivery technology platform from Kimberly-Clark

July 4, 2018

BeiGene identifies new PI3Kdelta inhibitors

July 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...